MedTrace Logo

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

NCT00262015 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2005-12-06

No results posted yet for this study

Summary

The purpose of this study is to determine when a memory immune response after re-vaccination with Meningococcal C conjugate vaccine (Menjugate) or challenge with Meningococcal A/C polysaccharide vaccine can be observed, after initial vaccination with Meningococcal C conjugate vaccine during the UK immunization campaign

Conditions

  • Meningococcal Disease; Meningococcal Meningitis

Interventions

BIOLOGICAL

· Meningococcal C conjugate vaccine; Meningococcal A/C Polysaccharide vaccine (partial dose)

Sponsors & Collaborators

  • Chiron Corporation

    lead INDUSTRY

Principal Investigators

  • Andrew J. Pollard, MBBS, FRCPCH, PhD · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00262015 on ClinicalTrials.gov